Biotest AG
BIESF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | $0 | $0 | $10 |
| Dep. & Amort. | – | $0 | $0 | $0 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $0 | $0 | $0 |
| Change in WC | – | $29 | $7 | $28 |
| Other Non-Cash | – | $8 | -$30 | $21 |
| Operating Cash Flow | – | $38 | -$23 | $58 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | $0 | $0 | $0 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | -$4 | -$7 | -$5 |
| Investing Cash Flow | – | -$4 | -$7 | -$5 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | $0 |
| Stock Issued | – | $0 | $0 | $0 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $50 | -$11 | -$72 |
| Financing Cash Flow | – | $50 | -$11 | -$72 |
| Forex Effect | – | -$0 | -$0 | $0 |
| Net Chg. in Cash | – | $83 | -$42 | -$19 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $25 | $66 | $85 |
| End Cash | – | $108 | $25 | $66 |
| Free Cash Flow | – | $9 | -$23 | $58 |